Company Email Format Management

NeoImmuneTech

Biotechnology Research 2400 Research Blvd. 40 employees

Employees: 40
Contacts: 2
Emails: 2

neoimmunetech.com LinkedIn Crunchbase

NeoImmuneTech Overview

Headquarters: 2400 Research Blvd.
Phone Number: Available in AeroLeads
Website: neoimmunetech.com
Industry: Biotechnology Research
Employees: 40
Founded: 2014
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About NeoImmuneTech

NeoImmuneTech, Inc. (NIT) is a clinical-stage T cell-focused biopharmaceutical company dedicated to expanding the horizon of immuno-oncology and enhancing immunity to infectious diseases. Our lead drug candidate, NT-I7, is the only clinical-stage long acting rhIL-7, and is uniquely positioned to address unmet medical needs in Immuno-Oncology and Infectious Diseases. IL-7 is a fundamental cytokine for lymphocyte development, survival, and memory development. Furthermore, NT-I7 has been shown clinically to have desired PK/PD and safety profiles, making it an ideal combination partner with T-cell targeted therapies. NT-I7 is being studied in multiple clinical trials and many in collaboration with industry leaders in I-O, including Merck and Roche for CPI combination trials. Follow us on X @neoimmunetech

NeoImmuneTech Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

NeoImmuneTech Org Chart

Sample employees and titles

Name	Title	Location	Contact
Alexandra Wolfarth, Phd	Lead Scientist at Neoimmunetech	Rockville, Maryland, United States	Email
Hayoung Lee	Neoimmunetech	Seongnam, Gyeonggi, South Korea, Korea, Republic of	View
Luke Oh	President & CEO, Neoimmunetech	Washington Dc-baltimore Area, United States	Email